Recursion Pharmaceuticals, Inc. (RXRX): calculated intrinsic value vs market price

Recursion Pharmaceuticals, Inc. (RXRX) valuation snapshot is loading. Our models compare market price to fair value using DCF, P/E, and P/S frameworks.

Fair value gap (live) — (from live valuation API)
Confidence (live) — (—)

Confidence score is based on the magnitude of the gap vs the modeled estimate.

Fair value estimate

Unlock fair value

Current price

$3.38

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE Calculator Stock Valuation Calculator

How to read the price vs calculated fair value gap for Recursion Pharmaceuticals, Inc.

Intrinsic value work for Recursion Pharmaceuticals, Inc. anchors fair value on owner earnings and balance-sheet capacity, then places the current quote next to that estimate.

Versus historical valuation bands, RXRX can sit toward the lower or upper end of where this business has traded when profitability and growth were comparable — useful context before reading any single headline multiple.

Sector peers and macro rates still deserve a sanity check on the company page. The percentage gap on this snapshot is a model output, not a recommendation.

Key metrics

P/E ratio: 33.5x
Revenue growth (TTM y/y): 18%
Profit margin: 36.5%
Fair value (model): Unlock

Next steps

Frequently asked questions — RXRX

What is RXRX’s calculated intrinsic value vs its market price?

Recursion Pharmaceuticals, Inc. (RXRX) current market price is $3.38. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.

What is Recursion Pharmaceuticals, Inc.'s intrinsic value?

Intrinsic value is an estimate of what RXRX shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Recursion Pharmaceuticals, Inc.'s intrinsic value calculated?

Tickerplace calculates RXRX's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.

How should I read RXRX’s fair value gap?

The fair value gap is the percentage difference between RXRX’s market price and the modeled fair value estimate. Use it as one research input alongside fundamentals — not as a recommendation.

Peers for RXRX: open their calculated fair value vs price view.

Calculated intrinsic value vs market price